The efficacy of albendazole-ivermectin combination was tes ted on adult and developing stages of Molinema dessetae in the rodent Proechimys oris. Albendazole and ivermectin, both given alone, suramin and diethylcarbamazine were used as reference compounds. The drug combination (albendazole at 10 mg/kg/ day x 5 days and Ivermectin at 0.04 mg/kg/day x 5 days) was effective against infective larvae and preadult worms, and substan tially reduced the number of live adult worms. The known filaricidal agents, diethylcarbamazine (400 mg/kg twice daily x 5 days), ivermectin (0.2 mg/kg/day x 5 days), and suramin (40 mg/kg/day x 5 days), as well as albendazole (50 mg/kg/day x 5 days) were active on infective larvae, preadult worms, microfi lariae and adult worms. All drugs had the same level of efficacity on infective larvae. Albendazole had the highest efficacy against adult and preadult worms and diethylcarbamazine was the most active on microfilariae. Although the drug combination was not as effective against preadult and adult worms as albendazole alone, the results indicate that albendazole-ivermectin combination at a low dose had prophylactic effect and suggest a possible macrofilaricidal activity.
INTRODUCTION
A t present the drugs available for treating and controlling human filariasis are unsatisfactory and limited. Hence there is an urgent need to find an effective, safe and easily administered drug that affects not just the adult worms and microfilariae but also the other immature stages (W.H.O., 1987) .
Suramin is the only proven onchocerca macrofilaricidal agent (Duke, 1991 ; Ottessen, 1985) , but its toxi city and intravenous dosing limit its use.
Several clinical trials have shown that ivermectin and diethylcarbamazine are useful for treating onchocercia sis and lymphatic filariasis respectively (Duke et al., 1990 ; Greene et al., 1990 Greene et al., , 1991 Prod'hon et al., 1991 ; Sharma et al, 1987 they have little or no effect against adult worms (Albiez et al., 1988 ; Eberhard et al, 1988 Eberhard et al, , 1991 . Their activity on developmental stages varies with the filarial species and the stage within the same species (Campbell, 1981 (Campbell, , 1982 Duke, 1968 ; Fujimaki et al., 1990 ; Kevin Baird et al, 1991 ; Paul et al., 1986) .
Flubendazole and mebendazole are active on third and fourth stages of different filarial species (Burbure et al, 1986 ; Katiyar et al, 1987) , as well as embryonic stages of O. volvulus (Rivas Alcala et al, 1981 a, b) . However, they are poorly absorbed orally. There is considerable interest in using albendazole in combination with ivermectin for the treatment of onchocerciasis as such a drug interaction may improve efficacy against worms (Awadzi et al, 1991 ; Hoaksey et al, 1990) . Albendazole is a powerful benzimiclazole carbamate involved in carbohydrate catabolism and tubulin synthesis. Ivermectin acts on the neuromuscular level (Vande-Waa, 1991) . Both products are intestinally well absorbed in man.
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We carried out a multidisciplinary study to investigate the host parasite relationship of the filaria Molinema dessetae Bain, 1973 and the rodent Proechimys oris under the influence of several different filaricidal drugs. This experimental model of filariasis has been showed to be a useful model for screening filaricidal compounds (Gayral et al, 1976 (Gayral et al, , 1982 (Gayral et al, b, 1989 . The aim of this paper is to report on the effects of albendazole-ivermectin combination against infective larvae, preadult worms, microfilariae and adult worms of M. dessetae.
Also studied were the effects of diethylcarbamazine and suramin, as well as alben dazole and ivermectin when administered alone. The influence of these drugs on macroscopic lesions due to filarial infection in P. oris is also reported. (Gantier et al., 1979; Gayral étal, 1982 a; Petit, 1978) .
MATERIALS AND METHODS

T he rodents
DRUGS AND DOSES
Four of the drugs were administered subcutaneously (Se) once a day over 5 successive clays (albendazole, ivermectin, albendazole-ivermectin combination and suramin) and one drug was administered orally (Or) twice a day over 5 successive days (diethylcarbama zine) (Gayral et al, 1982 b; Kani et al, 1986) . The drugs were suspended at 5 mg/ml in 1% carboxymethyl cellulose (CMC 1%) in distilled water, in which some 50 μΐ drops of polysorbate-80 (Tween) had been added. 
DESIGN OF TREATED AND CONTROL GROUPS
Five rodents were used per drug. For the rodents given the drug subcutaneously (4 drugs: 20 animals) there was one control group of 10 animals and for the rodents given the dmg orally (1 drug: 5 animals), five animals were used as control. The number of rodents used as control was calculated according to the total number of P. oris treated by Sc and Or routes (Lellouch & Lazar, 1974) . Rodents were alloca ted at random into treated and control groups.
The control groups of rodents, which were infected but left untreated, received a volume of CMC 1% with Tween equivalent to that received by the treated groups.
The activity of the drugs was evaluated on four filarial stages : infective larvae, preadult worms, microfilariae and adult worms. The drugs were administered four days post infection to evaluate the effects against infective larvae. To assess the efficacy on preadult worms, rodents were treated 47 days after inoculation. The drugs were given 189 days after infection to inves tigate their activity on microfilariae and adult worms. In this group, only rodents with 10 mf or more per 10 μΐ of blood were selected to assess micro-and macrofilaricidal efficacy. Dates of treatment were selected according to Gayral et al, 1982 a, b. COUNTING MICROFILARIAE Blood was taken from the retro-orbital venous plexus between 2 and 4 p.m. Giemsa-stained thick smears were prepared with ten microliters of blood and exa mined microscopically to determine the number of microfilariae.
The microfilaremia counts of rodents treated 189 days post infection were measured one week before treat ment and then weekly for six weeks following treat ment.
As microfilariae begin to appear in the blood on the 90th day after larvae inoculation, the microfilaremia of animals treated 47 days post inoculation was mea sured one day before or at the moment of the necropsy only.
ss Mémoire
FILARICIDAL DRUGS AGAINST Moumu DESSSTAE
Recovery of adult worms
Rodents were euthanized with ether six weeks after treatment and a complete autopsy was performed. Intraperitoneal live worms were recovered. Haematological, biochemical and complete pathology studies were also performed. These results will be reponed at a later date. The macroscopic findings of intraperitoneal nodules are reported here.
Statistical analysis
The nonparametric Wilcoxon rank sum test was used to compare the data obtained in each treated group with its corresponding control group. The differences were considered significant for a 5% risk (Schwartz, 1990) . Data are presented as arithmetic means and percentages of reduction.
RESULTS
EFFECTS ON MICROFILARIAE
T he microfilaremia counts obtained each week during the six weeks following treatment are expressed as a percentage of the initial pre treatment counts. Most of the drugs produced a sus tained reduction in microfilaremia levels following treatment (Fig. 1 ).
Albendazole caused a moderate microfilaremia reduc tion during the first two weeks (60% reduction by week two) that became very pronounced by week three (98% reduction) and remained stable from week four (99% reduction).
In animals treated with ivermectin, the microfilaremia counts fell moderately (69% by week one) and remai ned relatively stable over the six weeks following treatment (59% by week six).
With albendazole-ivermectin combination, there was an increase in microfilaremia levels of the rodents from the third week after treatment, which peaked by week four (84% increase), followed by a gradual reduction that remained higher than the pre-treatment counts (55% increase by week six).
The microfilaremia counts in rodents treated with sur amin fell progressively. The levels were reduced by 14% at the first week post-treatment and gradually decreased to 98% by the end of the study.
Microfilaremia levels fell rapidly in rodents treated with diethylcarbamazine. By the first post-treatment week, no microfilariae were found. The levels increa sed (1-2%) over weeks two to five but by week six the levels measured had fallen back to zero.
In the two control groups of rodents, the microfilare mia counts increased over the six weeks post-treat ment. The levels were similar for the two groups: they increased from 5% at the first post-treatment week to 36% by the end of the study. Fig. 1 . Microfilarial percentages one-week before treatment (0 week) and during the six weeks following treament (therapy at 189 days post-infection).
The number of rodents that became free of microfilariae after treatment varied according to the drug administe red. Diethylcarbamazine completely cleared microfilariae in all rodents. Albendazole, suramin and ivermectin cau sed complete clearance of microfilariae in 4 of 5, 3 of 5 and 2 of 5 rodents, respectively. In albendazole-ivermec tin combination and control groups no rodents became amicrofilaraemic during the study period.
EFFECTS ON ADULT WORMS
LIVE WORMS
T he mean number of live adult worms recove red from control and treated rodents is shown in Fig. 2 . Also shown is the percentage of reduction in the number of worms recovered compa red to controls. The mean number of adult worms recovered after treatment from both control groups was similar, between 8.9 and 9-4 worms. The two control groups also had similar mean counts for adult female worms (5.3 and 6.0 worms) and adult male worms (3-4 and 3-6 worms).
All of the drugs tested in the Molinema
dessetaeProechimys oris model reduced the worm burden by between 37% and 100%, relative to the number of worms recovered in the control groups. Albendazole was the most effective substance against the adult worms. No adult filariae were detected at autopsy. Suramine and diethylcarbamazine were both strongly active, producing similar reductions of 93%-94%, respectively, in the number of live worms when compared to controls. No male live worms were recovered in rodents treated with diethylcarbamazine. In contrast, suramine caused a reduction of 90% in the number of male worms compared to the control. Ivermectin caused a 71% reduction in the total num ber of live worms recovered after treatment when compared to control.
The live worm burden in rodents treated with alben dazole-ivermectin combination was reduced to 37% compared to the control group. There was a larger reduction in the number of male worms (44%) com pared to female worms (32%).
The differences between treated and control groups in the mean number of live adult worms recovered after treatment were statistically significant in all groups except the rodent group given albendazoleivermectin combination.
DEAD WORMS
An important finding was the presence of dead adult filariae surrounded by a yellow material in the abdo minal cavity of treated rodents. Two rodents in each of the five treated groups showed dead filariae. Of interest was the observation that in the group which IVM : ivermectin, ABZ : albendazole, ABIV : albendazole-ivermectin combination, SA : suramine, DEC : diethylcarbamazine. received albendazole-ivermectin combination one rodent had two dead worms. Only one dead worm per rodent was found in the other nine animals. No dead adult filariae were found in the control groups.
Effects on preadults : Figure 3 shows the mean number of live adult worms recovered from treated and control groups. Also shown is the percentage decrease in live adult worms recovered from treated groups compared to the live worm burden for control groups. The mean number of live adult worms recovered in the control groups was considered to be 100%.
Albendazole showed the highest activity, as no live adult worms were found in the five treated rodents at necropsy. The other four drugs showed high activities against preadult worms, the overall percentage reduc tion ranged from 70% to 95%, with diethycarbamazine (95%) and albendazole-ivermectin combination (85%) being the most active and ivermectin (77%) and suramine (70%) the least active. In rodents trea ted with albendazole-ivermectin combination, as well as those treated with diethycarbamazine, no live male worms were found. This was in contrast to animals treated with suramin or ivermectin where some live male and female worms were recovered. The lower mean numbers of live adult worms in trea ted groups were statistically significant. Moreover, no microfilariae were seen in the thick smear prepared from blood of the treated rodents, unlike with control rodents where a mean of 2.3 microfilariae per 10 pi of blood was observed.
Effects on infective larvae :
All the drugs were active against third stage larvae, as all treated rodents were negative for live worms at autopsy. In contrast, an average of three worms per rodent was found in the control groups. The diffe rence between the live worm recovery means of each treated group and its control group was statistically significant.
Effects on gross pathological lesions :
Intra-abdominal granulomas were the most common macroscopic finding seen at autopsy. They were found in all control animals and in those treated at 47 and 189 days post-infection (Table I) . Also, more gra nulomas were present in these treated rodents than in the controls. Interestingly, no granulomas were found in rodents treated four clays after inoculation. Most granulomas were found in the omentum. They were also seen, though less frequently, in the pelvis, diaphragm, retroperitoneum and free in the cavity. Their size ranged from 2 mm to 15 mm. but most were less than 5 mm. All granulomas were yellowish and friable. Vingtaing étal, 1988) .
The clearance of circulating microfilariae was com plete and quick in animals receiving diethylcarbama zine. It was slow and progressive in rodents given suramin and albendazole, with a reduction in microfi laremia between 98% and 99% in each group respec tively by the sixth week after treatment. Ivermectin was less active against microfilariae than the three above mentioned drugs. It produced a 59% reduction in the microfilaremia count by the end of the study. Albendazole produced a complete reduction in the number of live adult worms recovered at autopsy. Suramin, diethylcarbamazine and ivermectin were less active than albendazole on adult worms.
Albendazole-ivermectin combination caused a 37% reduction in the number of live adult worms compa red to control groups. The reduction was however non significant. The increase in the microfilaremia level seen in these animals cannot be explained from results obtained here. There are two possible expla nations for this increase. It may be the result of natu ral variation in microfilaremia. Another possible rea son is a still poorly understood non-lethal, toxic effect on adult female worms that induces a release of microfilariae from the uteri.
All drugs given alone showed complete activity on infective larvae. Albendazole was the most effective against preadult worms, as no live adult worms were seen at autopsy. The remaining drugs produced smal ler but significant activity on preadult worms. Albendazole-ivermectin combination showed a com plete effect against infective larvae. When given 47 days after inoculation, there was complete activity against males and an incomplete but significant effect on females. The drug combination was completely active on both male and female preadult worms in four rodents. In the fifth rodent, the drug combina tion had a complete effect on males and an incom plete effect on females.
The effect of the drug combination on preadult worms was greater than that of ivermectin when administered alone and slightly less than albendazole when used alone. Furthermore, ivermectin when given alone to chimpanzees, had a partial effect against infective larvae and no effect on later larval stages of O. volvulus (Taylor et al, 1988) . The presence of intra-abdominal granulomas in P. oris infected with M. dessetae has been associated with dead worms (Gantier et al, 1987) . The increase in the number of granulomas in treated groups when compared to control groups could be interpreted as a filaricidal effect. However, a histological examination of nodules is requi red to determine their nature. The lack of granulomas in rodents treated four days after inoculation could be due to infective larvae dying before arriving to the peritoneal cavity, as it takes around 14 days for the larvae to reach the cavity (Gayral et al, 1982 a) .
Albendazole used alone and administered by subcutaeous route was the most potent filaricidal drug tes ted. It had a complete effect on three developmental stages: adult, preadult and infective larvae. It was extremely active on microfilariae. The efficacy of this drug against infective larvae and on later larval stages has not been assessed in other animal models or human filariasis. In the Monanema martini model of onchocerciasis (Vuog-Ngoc, 1992) , the compound administered subcutaneously at 50 mg/kg daily over 5 days had incomplete activity on microfilariae and complete activity on adult worms in two animals but incomplete in the third rodent. Moreover, a clinical study carried out on 92 people infected with O. vol vulus showed that the principal effect of albendazole when given orally at 800 mg daily for 3 days was on all intra-uterine stages (Awadzi et al., 1991) .
(.2
The filaricidal effects of the albendazole-ivermectin combination has not been previosly examined in vivo. In the M. dessetae model, the effects of the drug combination on adult worms were not greater than that of both drugs when administered separately. This result should be interpreted with care as the dosage (which corresponded to 1/5 of the albendazole and ivermectin dosage when administered alone) was low and may have been borderline or inferior to the minimal effective dosage against adult worms. Also no activity was observed against microfilariae. It is probable that a higher dose could be effective against both microfilariae and adult M. dessetae.
In this case, the microfilaricidal effect would probably be slow and progressive. This may be advantageous as it could be associated with few or no secondary effects. In contrast, the most serious side effects, like Mazzotti reaction, are due to the massive and rapid death of microfilariae. Such an effect occurs with diethylcarbamazine (Ackerman, et al, 1990 ).
This study shows that the albendazole-ivermectin combination has prophylactic effect against M. dessetae infection and a likely macrofilaricidal activity. On the basis of these results, and the fact that ivermectin and albendazole are known safe drugs in man, it may be of considerable interest to examine the filaricidal activity of the albendazole-ivermectin combination in humans.
